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chocardiography-Guided Biventricular
acemaker Optimization
asneem Z. Naqvi, MD
os Angeles, California
ptimization of atrioventricular delay (AVD) and interventricular delay (VVD) in patients with a biventricu-
ar (Biv) pacemaker has been associated with improvement in cardiac output acutely, a reduction in heart
ailure symptoms, and improved exercise capacity. Several individual echocardiography (echo) Doppler
arameters have been used for pacemaker optimization. In this review, pacemaker optimization based on
chocardiographic evaluationof cardiachemodynamics is presented. Thegoals of this paper are todiscuss
tudies in echo-guidedpacemaker optimization, provide a systemicguide topacemaker interrogation and
ptimization in patients after Biv pacingwhomay have complex hemodynamic derangement, and finally,
o discuss studies in optimizationwith exercise or atrial pacing. Case examples highlightinghemodynamic
erangement in heart failure, tailoring of Biv pacemaker optimization to the underlying physiologic
erangement, and its improvement with optimization are presented. (J Am Coll Cardiol Img 2010;3:
168–80) © 2010 by the American College of Cardiology Foundationi
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edtroardiac resynchronization therapy (CRT)
has become a new, effective treatment
modality in those with drug-resistant
advanced congestive heart failure.
espite careful selection, as many as 30% to
0% of patients do not respond to CRT (1).
chocardiography (echo) optimization of
trioventricular delay (AVD) was included in
everal randomized trials in CRT (1–4). Ritter’s
ethod was used in the MIRACLE (Multi-
enter InSync Randomized Clinical Evaluation)
tudy (1), iterative method in CARE-HF (Car-
iac Resynchronization-Heart Failure) study (3)
nd a device-based algorithm was used in the
OMPANION (Comparison of Medical Ther-
py, Pacing and Defibrillation in Chronic Heart
ailure) study (2). In clinical practice, however,
iventricular (Biv) pacemaker optimization is of-
en overlooked (5), and AVD may be set empir-
rom the Echocardiographic Laboratories, Keck School of Medic
alifornia. Dr. Naqvi reports that she has research grants with Manuscript received January 7, 2010; revised manuscript received Maycally at an out-of-box setting of 120 ms (6–8) or
rogrammed based on currently available electri-
al algorithms (9). Currently available pacemak-
rs offer programmable AVD, interventricular
elays (VVD) (10), as well as rate-adaptive AVD
rogramming and rate-response features. The
urpose of this paper is to discuss the literature on
cho-guided optimization, discuss steps incorpo-
ating pacemaker interrogation, and demonstrate
tility of comprehensive echo to guide pacemaker
ptimization. Multiple examples of hemody-
amic Doppler abnormalities in heart failure
re cited.
tudies in Echo-Guided Pacemaker
ptimization
cho Doppler assessment of left ventricular
LV) diastolic filling and LV ejection has been
University of Southern California, Los Angeles,
nic and St Jude and is a consultant for St Jude.24, 2010, accepted June 8, 2010.
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1169he most commonly utilized method for pacemaker
ptimization. Several studies from single centers
ave shown improvement in cardiac output by
ailored echo Doppler-guided Biv pacemaker AVD
ptimization (3,11–13). One single, blind, random-
zed trial that investigated the impact of AVD
ptimization based on the aortic velocity time integral
VTI) showed improvement in New York Heart
ssociation (NYHA) functional class in optimized
ersus control patients (6). Similar to AVD optimiza-
ion, data from small, single-center studies demon-
trated that sequential Biv pacing after VVD optimi-
ation may acutely further improve LV stroke volume
10,13,14), LV dP/dt (15), and LV dyssynchrony
16); however, the incremental benefit of sequential
VD remains inconclusive in multicenter studies.
lthough sequence of AV versus VV optimization is
nclear, our own experience and other data (17)
uggest better results when AVD is optimized first.
his approach improves LV preload by ensuring
itral valve closure immediately after completion of
trial contraction, and in turn, cardiac output. Opti-
al AVD changes over time; however, no consistent
rend in AVD changes has been observed (18–20).
cho Doppler Techniques in
acemaker Optimization
oppler parameters used for echo-guided optimi-
ation include aortic VTI (21,22), diastolic mitral
ow pattern by Ritter’s method (23), iterative
ethod (24), diastolic filling time (3), VTI of mitral
nflow (25), Doppler-derived dP/dt (26), tissue
oppler imaging (13,14), LV and right ventricular
RV) pre-ejection delays, and myocardial perfor-
ance index (27). LV VTI has been shown to be
easible and more reproducible compared with mi-
ral inflow VTI and filling time as well as measures
f dyssynchrony (22). LV ejection duration has also
een used instead of LV VTI or peak ejection
elocity (28) (Figs. 1 and 2). optimization using
itter’s method versus aortic VTI has yielded conflict-
ng results in the same patients (21). We have shown
he utility of comprehensive methods using multiple
cho Doppler parameters in improving cardiac output
cutely and NYHA functional class at 1 month
29,30). A recent study showed that in nonresponders
o CRT, a multidisciplinary approach centered on Biv
acemaker optimization in a heart failure program,
an reduce the adverse event rate, including death,
ransplantation, and heart failure hospitalization (31).
Pacemaker optimization includes interrogation
f the pacemaker, evaluation of the baseline echo- Aardiogram, AVD optimization, VVD optimiza-
ion, determination of rate-adaptive AVD, and
etermination of appropriate sensitivity for rate
esponse.
The American Society of Echocardiography Ex-
ert Consensus Statement of 2008 (32) suggested a
implified AVD optimization method. However,
ue to variable results by individual Doppler param-
ters (21,22), we (29,30,33,34) and others (35,36)
ave used a pacemaker optimization method utiliz-
ng individual patient hemodynamics. The reader is
eferred to excellent reviews on pacemaker optimi-
ation using AVD (37) and VVD (38).
acemaker interrogation. Differences in Biv pace-
aker programming features in major pacemaker
evices are shown in Table 1. Pacemaker interro-
ation steps are listed in Table 2. Increasing atrial
r ventricular pulse width and/or amplitude may
nable atrial and/or Biv pacing. Increased
trial pacing rate (to 70 to 85 beats/min)
ay decrease or eliminate frequent atrial
nd/or ventricular premature beats (Fig.
). Continuous atrial sensing or pacing
hould be used during AVD optimization.
f a patient is intermittently sensing and
acing at heart rates between 60 and 70
eats/min, decreasing the backup atrial
acing rate to 50 to 55 beats/min may
llow optimization during complete atrial
ensing, whereas increasing atrial pacing
o 65 to 70 beats/min may allow optimi-
ation during complete atrial pacing when
he intrinsic rate is less than 65 beats/min.
he “A-fib suppression” feature may have
o be turned OFF to prevent increased
aced atrial rate in those with atrial ectopy. Sleep
pnea may cause a large variation in pulsed wave
PW) Doppler parameters during apneac versus
yperpneac phase of respiratory cycle due to varia-
ion in heart rate: bradycardia and ventricular ec-
opy during apnea and tachycardia during hyper-
nea, increase in mitral regurgitation (MR) during
radypnea or apnea (Fig. 4), and marked interven-
ricular dependence due to extreme shifts in in-
rathoracic pressure during hyperpnea (33), hence
he recognition of sleep apnea is important before
ptimization is attempted.
aseline echocardiogram. A comprehensive evalua-
ion by a skilled sonographer, preferably with a
upervising cardiologist, of baseline echo Doppler
emodynamics and filling pressures at the baseline
acemaker settings (38,39) should be performed.
A B B
A N D
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1170Figure 1. Determination of Optimal AVD by the Ritter Method
Atrial truncation at a short atrioventricular delay (AVD) of 50 ms (A), E and A fusion at a long AVD of 250 ms (B), and optimal mitral
inﬂow at an AVD of 120 ms (C). A corresponding change in left ventricular (LV) velocity time integral (VTI) and ejection duration is seen
in D through F. Highest LV VTI of 18.8 cm is shown in F at optimal AVD. Ritter’s formula is shown at the bottom of the ﬁgure, where QA
is time from onset of QRS to end of mitral inﬂow A-wave. Note that diastolic mitral inﬂow ﬁlling time is longest (421 ms) at a short AVD
of 50 ms that is not optimal.B A C 
E D F 
H G 
I J 
Figure 2. Determination of Optimal AVD by Iterative Method
Iterative method of AV optimization. An AVD of 50 ms (A) leads to premature closure of the mitral valve. Progressive increases in AVD
from 80 ms (B) to 170 ms (C) lead to progressive improvement in mitral inﬂow A-wave (white arrows, B and C) along with correspond-
ing improvement in LV VTI (D–F). AVD of 180 ms produces the best mitral inﬂow E and A combination (G), whereas 250 ms leads to
marked E and A approximation and reduction in diastolic ﬁlling time (H). LV VTI shows the highest value (15.62 cm) at AVD of 180 ms (I)
and deteriorates at 250 ms (J). Abbreviations as in Figure 1.
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1171peed settings are critical in ensuring correct mea-
urements and for best temporal and spatial resolu-
ion. An optimized diastolic filling allows E and A
eparation, making the end of mitral inflow A-wave
oincide with the R-wave of the electrocardiogram,
hus preventing atrial truncation (Fig. 1) and avoid-
ng diastolic MR. Presence of an abnormal relax-
tion pattern on mitral inflow Doppler usually
ndicates adequate AVD programming (32,33), al-
hough exceptions are not uncommon, whereas
seudonormal or restrictive mitral inflow pattern,
Table 1. Differences in Major Manufacturer’s Devices
Medtr
Model Consulta CRT-D
Sensed AVD 30–350 ms
Paced AVD 30–350 ms
AVD increase 200 ms 10 ms
AVD Increase 200 ms 10 ms
VVD baseline LV ﬁrst 4 ms
VVD programmable LV 0-80 ms
VVD programmable RV 0-80 ms
VVD increments 10 ms
Effect of LV offset on LV AVD None
Effect of LV offset on RV AVD Increases proportiona
Rate-adaptive AVD onset 60 beats/min
Rate-adaptive AVD shortening Linear response b/w p
Rate-adaptive AVD manually programmable Yes
Rate-response sensing mechanism Accelerometer
AVD  atrioventricular delay; b/w  between; LRL  lower rate limit; LV  le
programmable delay is 15 ms for LV ﬁrst.
Table 2. Pacemaker Interrogation
1. Percentage Biv pacing. If 95%, consider signiﬁcant atrial or
ventricular ectopy, atrial arrhythmia.
2. Percentage atrial pacing, VV offset, atrial and ventricular lead
sensing and pacing threshold, increased atrial or ventricular
lead thresholds, and programming of AVD at or above
intrinsic AVD.
3. Heart rate. Fixed heart rate on heart rate histogram may be
due to chronotropic incompetence or lack of use of rate-
response features or decreased sensitivity settings for rate
response or may indicate a signiﬁcant limitation in physical
activity.
4. Intrinsic AVD. This determines range of AVDs available for
programming. A high intrinsic AVD due to poor AV
conduction allows a greater range of AVDs for programming.
5. Determine backup atrial pacing rate, turn it up to suppress
ectopy and down to physiological levels (60 beats/min) to
allow atrial sensing.
6. Determine heart rate variability, rate response, rate-response
sensitivity, lead thresholds.
7. Exclude presence of sleep apnea by using the respirometer
on the ultrasound system.sBiv  biventricular; VV  interventricular; other abbreviation as in Table 1.runcation, or absence of A-wave (despite presence
f sinus rhythm), and E and A fusion suggest the
eed to adjust AVD (32). Presence of prominent
ulmonary vein atrial reversal may indicate that the
VD is too short (39) (Fig. 5). Presence of diastolic
R by color Doppler gated to electrocardiogram
ignal, and better by continuous wave Doppler, and
and A fusion indicate that the AVD is too long
Fig. 5). Decreased dP/dt, increased aortic pre-
jection time, restrictive mitral and pulmonary vein
nflow pattern, presence of MR, and increased
ulmonary artery systolic pressure are nonspecific
arkers of advanced LV dysfunction and/or in-
reased LV end diastolic and left atrial pressure, and
re a useful guide during pacemaker optimization
29,30). Improvement in LV and RV dP/dt (Fig.
), shortening of aortic pre-ejection delay, conver-
ion to a less restrictive mitral and/or pulmonary
nflow pattern (Fig. 6), reduction in RV–right atrial
radient (Fig. 5), reduction in systolic MR (Fig. 7)
nd tricuspid regurgitation, and elimination of di-
stolic MR or tricuspid regurgitation should be the
oal. Thus, in some patients, mitral inflow filling
ime needs to be compromised by allowing some
trial wave truncation to avoid diastolic MR. In
thers, improvement in pulmonary vein filling pat-
ern to a less restrictive type dominates the choice of
ptimal AVD or VVD setting (Fig. 6), whereas in
thers, systolic MR (Fig. 7) or diastolic MR (Fig. 5)
uides optimization along with LV VTI and dia-
St. Jude Boston
PromoteRF (36) Cognis
25; 30–325 ms 30–300 ms
25; 30–300 ms 30–300 ms
10 ms 10 ms
25 ms 20 ms
LV ﬁrst 10 ms LV ﬁrst 5 ms
0–80 ms 0–100 ms
0–80 ms None
5 ms* 10 ms, LV only
None Shortens proportion
Increases proportionately None
90 beats/min b/w LRL and UTR
rammable rates Programmable 1-, 2-, or 3-ms
shortening per 1 beat/min
in rate (low, normal, high)
Linear response b/w
No Yes
Electrical activity and
accelerometer
Accelerometer
ntricular; RV  right ventricular; UTR  upper tracking rate; VVD  interventricuonic Scientiﬁc
ately
tely
rog programmable rates
ft ve lar delay. *First availabletolic filling evaluation. Improvement in most or all
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1172f these aforementioned echo Doppler features
early always predicts a significant improvement in
he patient’s functional class after optimization (5).
sing this method, we have demonstrated an im-
rovement, not only in diastolic filling parameters,
V ejection duration, and VTI, but also in MR
rade, pulmonary artery pressure, as well as myo-
ardial performance index (29), and in functional
lass at follow-up (30). Whether optimal mitral
nflow also provides optimal preload for RV has not
een evaluated and needs further study.
acemaker programming in resting conditions.
ETERMINATION OF OPTIMAL AVD. AVD optimi-
ation is generally performed before VVD optimi-
ation (Table 2). VV offset is turned OFF and
ptimal AVD is determined by Ritter’s method
sing mitral inflow PW Doppler (23) (Fig. 1). This
s done by using a combination of a short AVD and
he longest AVD that still provides complete Biv
apture. Start with 50 ms to 70 ms AVD and
rogressively increase AVD in increments of 10 to
0 ms. The shortest AVD at which mitral inflow
-wave is seen is considered the shortest AVD. A
ong AVD, such as 250 ms, is then programmed. If
here is native AV conduction at this AVD (as
vident by change in surface QRS on the ultrasound
Effect of Atrial Pacing Rate and AVD LV Filling and Ejection
VD optimization on diastolic function and LV ejection. To suppress ve
arked restrictive mitral inﬂow with tall E-wave, short deceleration tim
pulsed wave (PW) Doppler shows decreased peak velocity of 0.5 m/
ity) indicating advanced LV dysfunction (B). At an optimal AVD of 17
ued; however, LV ejection velocities increased to 0.6 m/s (D). Increas
hed pulsus alternans pattern on LV outﬂow Doppler (F). Abbreviationonitor [Fig. 8] and from intracardiac electro- mrams), AVD is decreased in 20-ms decrements
ntil fusion pattern and then complete Biv capture
ccurs on surface and intracardiac electrograms.
itral inflow is then evaluated at this “long” AVD.
ot infrequently, AVD above 250 ms needs to be
ested. Review of QRS from the image stored at the
hortest AVD helps ensure that the QRS morphol-
gy at highest AVD has resemblance to that at the
hortest AVD to confirm Biv pacing (Fig. 8).
arking the transition in QRS morphology is
elpful (Fig. 8). Ritter calculation [(AVD long 
A short)  (AVD short  QA short)  AVD
hort, where QA  time from onset of QRS to the
nd of A-wave on mitral inflow] is made from the
itral inflow at shortest and longest AVD (23).
ubtracting the time interval between end of trans-
itral A-wave and onset of systolic MR from the
rogrammed AVD is another quick method of
etermining optimal AVD (40). Occasionally, 30-
o 50-ms AVD is optimal and causes the best E
nd A separation (Fig. 9). Not infrequently, AVD
Fig. 2) of 300 ms is optimal. AVD above and
elow the Ritter’s optimal AVD is tested until best
cho Doppler parameters are achieved. It is impor-
ant to ensure that optimal mitral inflow is associ-
ted with improved LV VTI, ejection duration, and
cular ectopy, the atrial pacing rate was increased to 80 beats/min
nd a small A-wave is shown at baseline at an AVD of 110 ms (A).
d pulsus alternans pattern (alternating increase and decrease in
s, mitral inﬂow (C) became less restrictive. Pulsus alternans pat-
trial pacing to 90 beats/min further improved mitral inﬂow (E)
in Figure 1.Figure 3.
Effect of A ntri
at onset. M e, a
LV outﬂow s an
peak veloc 0 m
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1173ulmonary artery pressure. Evaluation of pulmonary
ein flow allows indirect assessment of left atrial
ressure. AVD that causes minimal atrial reversal, a
ystolic dominant filling pattern, and lengthening of
ulmonary vein deceleration time should be used to
inimize left atrial pressure (29,30) (Figs. 4, 6, and 10).
n patients with mitral valve closure before pacemaker
pike at long AVDs, the iterative method may be used
hereby AVD is progressively increased in 10- to
5-ms increments from the shortest AVD (Fig. 2) or
rogressively reduced in 10- to 25-ms decrements
rom the longest AVD that provides Biv capture
ithout fusion until the optimal mitral inflow pattern
s obtained without atrial truncation or E and A
usion. It is to be noted that the longest diastolic filling
ime—often present at the shortest AVD—is not
Figure 4. Pulmonary Vein Atrial Reversal and Diastolic MR at Sh
Effect of a very short atrioventricular delay (AVD) on mitral inﬂow a
on mitral inﬂow and MR in C and D. A short AVD leads to absence
white arrow). Prolonged AVD causes E and A approximation (C), sh
mitral regurgitation (MR) (white arrows, D). (E) Shows intermittent
lution at an AVD of 80 ms (F). Diastolic tricuspid regurgitation is sh
AVD of 80 ms (H) and a reduction in right ventricular–right atrial glways optimal (Fig. 1). (ETERMINATION OF OPTIMAL VVD. VVD only op-
imization has a role in patients in whom AVD
annot be optimized such as those with atrial fibrilla-
ion. Small, single-center studies (13–16) including
ur experience (29,30) demonstrate incremental ben-
fit of VVD optimization after AVD optimization.
arge, nonrandomized studies have shown acute ben-
fit of VVD optimization and improved follow-up
xercise capacity (10,14), whereas large, randomized
tudies (41,42) have not found benefit of sequential
ersus Biv pacing with nominal delay.
Prior studies have shown the utility of assessing
yocardial displacement using tissue Doppler (16)
s well as PW tissue Doppler (13). The range of
ptimal VVD is relatively narrow and most com-
only involves LV pre-excitation within 20 ms
and Long AVDs
ulmonary vein inﬂow is shown in A and B and that of long AVD
itral inﬂow A-wave and marked pulmonary vein atrial reversal (B,
ning of diastolic ﬁlling time (C), and appearance of diastolic
tolic MR (white arrow) at an AVD of 130 ms with complete reso-
at an AVD of 200 ms (white arrows, G) with resolution at an
nt in H compared with G.ort
nd p
of m
orte
dias
own14). Automated color-coded velocity maps provide
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1174uick assessment of segmental LV and RV delays
nd their change with VVD changes (32,33) (Fig.
1) or in myocardial displacement and function.
he majority of studies on VVD optimization have
sed LV VTI (10,22), whereas other studies have
sed myocardial performance index (20) and VVD
y PW Doppler of LV and RV outflow (27). Mitral
nflow is re-evaluated after optimal VV program-
ing and AVD readjusted if required. AVD ad-
ustment is usually not required with Medtronic
Minneapolis, Minnesota) or St. Jude’s (St. Jude
edical, St. Paul, Minnesota) devices; however,
Figure 5. Effect of Cheyne-Stokes Respiration on Cardiac Hemo
Effect of Cheyne-Stokes respiration on ventricular ectopy (A and B)
(MR) (G and H) in 4 different patients. Respirograms are shown by
is shown during hyperpnea (A) and apnea (B). O2 saturation varied
(92 beats/min) is shown during hyperpnea (C), and bradycardia (60
stolic ﬁlling time is shown in E during bradycardia at an atrioventri
(F) during hyperpnea and increased heart rate at the same AVD. Hy
whereas hypopnea is associated with bradycardia and marked reduith a Boston Scientific (Natick, Massachusetts) qevice, AVD needs to be increased by the amount
f LV offset and decreased by the amount of RV
ffset (Table 1). With a Medtronic device, in-
reased LV pre-excitation may lead to fused rhythm
n RV. Current generation pacemakers do not allow
hortening of VVD, hence a large resting VVD at
ower heart rates may be excessive for a shorter RR
nterval during exercise and may produce inter- and
ntraventricular dyssynchrony at higher heart rates
r may even lead to loss of RV or LV capture due
o shortening of intrinsic AVD during exercise.
his may explain lack of beneficial effects of se-
amics
rt rate (C and D), mitral inﬂow (E and F), and mitral regurgitation
n tracing above the electrocardiogram. Marked ventricular ectopy
ween 79% in late apnea to 94% pre-apnea. Increased heart rate
ts/min) during apnea (D). E and A separation and increased dia-
r delay (AVD) of 210 ms, and E and A approximation is shown in
pnea is associated with moderate mitral regurgitation (MR) (G),
n in MR severity (H).dyn
, hea
gree
bet
bea
cula
peruential VVD.
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1175E
A
E
A
S D
S
D
S
D
S D
D
C
F
B
S
D
Figure 6. Optimized Biv Pacing Improves Restrictive Diastolic Filling and LA Pressure
PW Doppler of mitral (A) pulmonary vein inﬂow (B) and continuous wave Doppler of the mitral regurgitation (MR) jet (C) during native rhythm in a
77-year-old woman with New York Heart Association (NYHA) functional class III. The pacemaker was programmed at a paced atrial rate of 80 ms,
paced AVD of 150 ms, and interventricular (VV) offset of 0 ms. Marked E and A fusion (A), restrictive pulmonary inﬂow pattern with S:D wave rever-
sal (B), and decreased LV dP/dt (blue bars at 1 m/s and 3 m/s of MR envelope) (C) is shown at native rhythm (AVD 250 ms). Premature ventricular
complexes (PVCs) are shown by a white arrow in B and C. Atrial rate was lowered to 65 beats/min, and an AVD of 50 ms produced a marked
improvement in diastolic ﬁlling pattern (D) and improvement in left atrial (LA) pressure as shown by pulmonary vein ﬁlling pattern (E). Improvement
in LV dP/dt during biventricular (Biv) pacing is shown (F). Note the increase in LV–LA gradient as shown by peak MR velocity of 4.9 m/s (96 mm Hg)
during Biv pacing (F) compared with 4 m/s (64 mm Hg) during native conduction (C), indicating lowering of left atrial pressure. Abbreviations as in
Figure 1.Figure 7. Effect of Changes in AVD on MR
Effect of changes in AVD on MR in a patient with NYHA functional class II after cardiac resynchronization therapy (CRT). AVD was pro-
grammed at 350 ms by the primary care physician. Moderate to severe MR during native rhythm (AVD 350 ms) is shown (A). Biv pacing
at an AVD of 250 ms led to a reduction in MR severity (B). Further decrease in AVD to 130 ms led to a further reduction in MR severity
(C). Mild MR is seen at an optimal AVD of 160 ms (D). Signiﬁcant improvement in symptoms occurred after optimization. Abbreviations
as in Figures 1, 2, 4, and 6.
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1176xercise and pacemaker optimization. Patients with
ilated cardiomyopathy have prolongation of LV
ystole and an abnormal shortening of LV diastole
Figure 8. Evaluation of Surface QRS to Determine Biv Pacing
Surface QRS on the ultrasound monitor from lead III in response to
ing transition from native rhythm at an AVD of 200 ms to a short A
biventricular (Biv) pacing (transition). (B) QRS at 140 ms shows mor
complexes. C shows transition from an AVD of 130 ms to 80 ms (w
indicating complete Biv pacing at an AVD of 80 ms. D shows transi
phology similar to that in A, suggesting complete Biv pacing.
Effect of RV Pre-Excitation on LV AVD in Medtronic Device
terventricular delay on mitral inﬂow in a patient with a Medtronic Bi
on at an AVD of 100 ms and LV pre-excitation of 20 ms at baseline, a
ause in Medtronic devices, RV pre-excitation causes a proportionate
w (C). Shortening of AVD to 30 ms led to E and A separation (D). E and
ms (E) and 50 ms (F). Note the E and A fusion in E and separation in F.
eart rate. Abbreviations as in Figures 1 and 4.t rest that is accentuated during exercise (43,44).
n addition, abnormal shortening of LV diastolic
ime requires higher left atrial pressures to maintain
oventricular delay (AVD) changes are shown. A was obtained dur-
of 50 ms. Note the complete change in QRS pattern (A) during
logy in-between native and Biv-paced rhythm representing fusion
arrow). The QRS morphology changes back to that shown in A,
from an AVD of 130 ms to 100 ms (white arrow) and QRS mor-
vice at a paced atrial rate of 75 beats/min. A shows marked E
B shows further E and A approximation with RV pre-excitation of
ase in LV AVD. Shortening of AVD to 60 ms led to no change in
ere obtained at an increased paced atrial rate of 90 beats/min at an
illustrates that occasionally, AVD may need to be increased at anatri
VD
pho
hite
tionFigure 9.
Effect of in v de
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1177V filling during exercise, resulting in pulmonary
ongestion and exercise intolerance (45). Modern
acemaker devices allow rate-response as well as
ate-adaptive AVD shortening during exercise.
Figure 10. Effect of Atrial Pacing on LV Filling and Ejection
Mitral inﬂow (A and B), pulmonary vein inﬂow (C and D), and LV o
and E) and optimal (A-paced 60 beats/min, AVD 300 ms: B, D, and
occurred (B), and pulmonary vein pattern became S dominant with re
pressure. An improvement in percentage LV ejection time also occurre
Figure 11. Effect of Sequential Ventricular Pacing on Mechanica
Tissue synchronization images are shown in the apical 4-chambe
ments are coded in a progressive sequence of green, yellow, or
210 ms. Delay in systolic contraction is shown in the basal latera
(white arrows in A). Homogenous contraction in LV and RV is se
on mechanical asynchrony is shown in another patient in C and
pre-excitation of 20 ms. Marked delay in the RV free wall and in
settings. RV and septal delay decreased progressively as the VVD
ms (D). Abbreviations as in Figures 1, 4, and 6.owever, current rate-adaptive AVD algorithms
re based on data derived from patients with con-
uction abnormalities (45,46), who had otherwise
reserved RV and LV systolic function. Little is
w PW Doppler (E and F) at baseline (A-sensed AVD 120 ms: A, C,
acemaker settings. An increase in A waves and decreased E/A ratio
d D-wave deceleration time (D), indicating reduction in left atrial
). Abbreviations as in Figures 1 and 2.
ynchrony
w. Normal segments are coded in green, and delayed seg-
e, and red. A is at a VV offset of 0 ms and optimal AV delay of
ll, basal inferior interventricular septum, and RV free wall
after LV pre-excitation of 30 ms (B). Effect of RV pre-excitation
acemaker was programmed at sensed AVD of 100 ms and LV
entricular septum (white arrows in C) was present at baseline
re changed to VV 0, right ventricular offset of 10, and then 15utﬂo
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1178nown about the magnitude of AVD shortening with
ncreased heart rate in heart failure patients and
hether AVD should be shortened, kept constant
47,48), or prolonged (49) as heart rate increases.
ecent studies suggest that AVD changes during
xercise are variable (50). Another study found that
chocardiographic diastolic filling time and stroke
olume were better during exercise using shorter than
aseline AVD (Fig. 12) (51). The effect of optimiza-
ion at increased heart rate requires further studies.
urrent Limitations of Pacemaker Programming
n evaluation of complex programming features
hould be part of pacemaker optimization. Adjust-
ent of heart rate, atrial-pacing versus atrial-
ensing, and often times, evaluation of other Dopp-
er parameters are required for pacemaker
Figure 12. Increased Atrial Pacing Rate Requires Progressive Sh
Mitral inﬂow PW Doppler tracing at optimal AVD of 190 ms and LV
min, and AVD was kept ﬁxed at 190 ms. Marked E and A fusion dev
and A separation occurred (C). Paced atrial rate was then increased
oped again (D). Progressive shortening of AVD to 90 ms (E), and th
ening of AVD to 70 ms led to shortening of mitral inﬂow A-wave a
atrial rate of 70 beats/min was 120 ms, and at 80 beats/min was 80tor in advanced chronic heart failure.
N Engl J Med 2004;350:2140–50. et al. Combined calectrophysiology, and echo specialists is needed for
uccessful heart failure programs incorporating
acemaker optimization (31). The benefit of VVD
rogramming remains controversial and requires
urther evaluation. Use of rate-response and rate-
daptive AVD programming requires more in-
epth study. An anticipated increase in complexity
f pacemaker designs, including use of dual/
ultiple LV and/or RV leads and/or electrodes and
eed for reprogramming, is expected to make pace-
aker optimization more complex. Randomized
ontrolled trials comparing adjunct and alternate
echniques are needed, with long-term clinical end
oints.
eprint requests and correspondence: Tasneem Z. Naqvi,
510 San Pablo Street, Suite 322, Division of Cardiology,
niversity of Southern California, Los Angeles, Califor-
ning of AVD
et of 0 ms (A). Atrial pacing rate was then increased to 70 beats/
ped (B). AVD was then progressively shortened to 120 ms until E
0 beats/min at the AVD of 120 ms. Marked E and A fusion devel-
0 ms (F) caused mitral inﬂow E and A separation. Further short-
remature closure of mitral valve. Hence, optimal AVD at a paced
. Abbreviations as in Figures 1 and 2.optimization. Collaboration among heart failure, nia 90033. E-mail: tnaqvi@usc.edu.E F E R E N C E S
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